| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Maribavir | 3.40 | Intermediate level resistance | Laboratory strain | Recombinant | Details | Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo. (Aug 2012) | |
| Ganciclovir | 1.02 | No resistance | Laboratory strain | Recombinant | Details | Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo. (Aug 2012) |